{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:16:16Z","timestamp":1778915776162,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T00:00:00Z","timestamp":1433203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00774-015-0665-3","type":"journal-article","created":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T23:56:22Z","timestamp":1433202982000},"page":"216-224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The importance of assessing the rate of bone turnover and the balance between bone formation and bone resorption during daily teriparatide administration for osteoporosis: a pilot study"],"prefix":"10.1007","volume":"34","author":[{"given":"Shinichi","family":"Nakatoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,2]]},"reference":[{"key":"665_CR1","doi-asserted-by":"crossref","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy (2001) JAMA 285:785\u2013795","DOI":"10.1001\/jama.285.6.785"},{"key":"665_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00774-012-0392-y","volume":"31","author":"Y Nishizawa","year":"2013","unstructured":"Nishizawa Y, Ohta H, Miura M, Inaba M, Ichimura S, Shiraki M, Takada J, Chaki O, Hagino H, Fujiwara S, Fukunaga M, Miki T, Yoshimura N (2013) Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition). J Bone Miner Metab 31:1\u201315","journal-title":"J Bone Miner Metab"},{"key":"665_CR3","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra067395","volume":"357","author":"E Canalis","year":"2007","unstructured":"Canalis E, Giustina A, Bilezikian JP (2007) Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 357:905\u2013916","journal-title":"N Engl J Med"},{"key":"665_CR4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0749-0690(02)00074-5","volume":"19","author":"MR Rubin","year":"2003","unstructured":"Rubin MR, Bilezikian JP (2003) The anabolic effects of parathyroid hormone therapy. Clin Geriatr Med 19:415\u2013432","journal-title":"Clin Geriatr Med"},{"key":"665_CR5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bone.2010.05.022","volume":"47","author":"A Miyauchi","year":"2010","unstructured":"Miyauchi A, Matsumoto T, Sugimoto T, Tsujimoto M, Warner MR, Nakamura T (2010) Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label phases. Bone 47:493\u2013502","journal-title":"Bone"},{"key":"665_CR6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-2362.2009.02087.x","volume":"39","author":"C Bieglmayer","year":"2009","unstructured":"Bieglmayer C, Kudlacek S (2009) The bone marker plot: an innovative method to assess bone turnover in women. Eur J Clin Invest 39:230\u2013238","journal-title":"Eur J Clin Invest"},{"key":"665_CR7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00774-013-0447-8","volume":"31","author":"S Soen","year":"2013","unstructured":"Soen S, Fukunaga M, Sugimoto T, Sone T, Fujiwara S, Endo N, Gorai I, Shiraki M, Hagino H, Hosoi T, Ohta H, Yoneda T, Tomomitsu T (2013) Diagnostic criteria for primary osteoporosis: year 2012 revision. J Bone Miner Metab 31:247\u2013257","journal-title":"J Bone Miner Metab"},{"key":"665_CR8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00198-008-0748-2","volume":"20","author":"E Barrett-Connor","year":"2009","unstructured":"Barrett-Connor E, Weiss TW, McHorney CA, Miller PD, Siris ES (2009) Predictors of falls among postmenopausal women: result from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int 20:715\u2013722","journal-title":"Osteoporos Int"},{"key":"665_CR9","first-page":"133","volume":"22","author":"S Nakatoh","year":"2014","unstructured":"Nakatoh S (2014) (Utility of calculations bone turnover rates and bone formation\/resorption ratios in osteoporosis care). Osteoporosis Jpn 22:133\u2013140","journal-title":"Osteoporosis Jpn"},{"key":"665_CR10","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1359\/jbmr.081215","volume":"24","author":"R Eastell","year":"2009","unstructured":"Eastell R, Nickelsen T, Marin F, Barker C, Hadji P, Farrerons J, Audran M, Boonen S, Brixen K, Gomes JM, Obermayer-Pietsch B, Avramidis A, Sigurdsson G, Gluer CC (2009) Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled European Study of Forsteo (EUROFORS). J Bone Miner Res 24:726\u2013736","journal-title":"J Bone Miner Res"},{"key":"665_CR11","first-page":"926","volume":"20","author":"P Chen","year":"2005","unstructured":"Chen P, Satterewhite JH, Licata AA, Lewiecki EM, Sipos AA, Misurski DM, Wagman RB (2005) Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis. J Bone Miner Res 20:926\u2013970","journal-title":"J Bone Miner Res"},{"key":"665_CR12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1185\/030079905X75096","volume":"22","author":"R Eastell","year":"2006","unstructured":"Eastell R, Krege JH, Chen P, Glass EV, Reginster JY (2006) Development of an algorithm for using P1NP to monitor treatment of patients with teriparatide. Curr Med Res Opin 22:61\u201366","journal-title":"Curr Med Res Opin"},{"key":"665_CR13","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.bone.2010.12.006","volume":"48","author":"M Tsujimoto","year":"2011","unstructured":"Tsujimoto M, Chen P, Miyauchi A, Sowa H, Krege JH (2011) P1NP as an aid for monitoring patients treated with teriparatide. Bone 48:798\u2013803","journal-title":"Bone"},{"key":"665_CR14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","volume":"22","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Eastell R, Bruyere O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JA (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391\u2013420","journal-title":"Osteoporos Int"},{"key":"665_CR15","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00198-004-1634-1","volume":"15","author":"M Ike","year":"2004","unstructured":"Ike M, Akiba T, Matsumoto T, Nishino H, Kagamimori S, Kagawa Y, Yoneshima H (2004) Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study. Osteoporos Int 15:981\u2013991","journal-title":"Osteoporos Int"},{"key":"665_CR16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9343(96)00387-7","volume":"102","author":"CH Chesnut","year":"1997","unstructured":"Chesnut CH, Bell NH, Clark GS, Drinkwater BL, English SC, Johnston CC, Notelovitz M, Rosen C, Cain DF, Flessland KA, Mallinak NJS (1997) Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density. Am J Med 102:29\u201337","journal-title":"Am J Med"},{"key":"665_CR17","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1359\/jbmr.1998.13.9.1431","volume":"13","author":"SL Greenspan","year":"1998","unstructured":"Greenspan SL, Parker RA, Ferguson L, Rosen HN, Maitland-Ramsey L, Karpf DB (1998) Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. J Bone Miner Res 13:1431\u20131438","journal-title":"J Bone Miner Res"},{"key":"665_CR18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S8756-3282(99)00087-3","volume":"24","author":"P Garnero","year":"1999","unstructured":"Garnero P, Darte C, Delmas PD (1999) A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover. Bone 24:603\u2013609","journal-title":"Bone"},{"key":"665_CR19","first-page":"845","volume":"58","author":"Y Cao","year":"2012","unstructured":"Cao Y, Lui X, Xu H (2012) Utility of serum tartrate-resistant acid phosphatase isoform 5b, bone alkaline phosphatase and osteocalcin in osteoporotic fractures in Chinese patients. Clin Lab 58:845\u2013850","journal-title":"Clin Lab"},{"key":"665_CR20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00774-012-0403-z","volume":"31","author":"T Yamamoto","year":"2013","unstructured":"Yamamoto T, Tsujimoto M, Hamaya E, Sowa H (2013) Assessing the effect of baseline status of serum bone turnover markers and vitamin D levels of efficacy of teriparatide 20\u00a0\u03bcg\/day administrated subcutaneously in Japanese patients with osteoporosis. J Bone Miner Metab 31:199\u2013205","journal-title":"J Bone Miner Metab"},{"key":"665_CR21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1359\/jbmr.090731","volume":"25","author":"P Aspenberg","year":"2010","unstructured":"Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, Garcia-Hernandez PA, Recknor CP, Einhorn TA, Dalsky GP, Mitlak BH, Fierlinger A, Lakshmanan MC (2010) Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res 25:404\u2013414","journal-title":"J Bone Miner Res"},{"key":"665_CR22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00223-012-9587-4","volume":"90","author":"J Goldhahn","year":"2012","unstructured":"Goldhahn J, Feron JM, Kanis J, Papapoulos S, Reginster JY, Rizzoli R, Dere W, Mitlak B, Tsouderos Y, Boonen S (2012) Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper. Calcif Tissue Int 90:343\u2013353","journal-title":"Calcif Tissue Int"},{"key":"665_CR23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/BOT.0b013e31828e13fe","volume":"28","author":"D Zhang","year":"2014","unstructured":"Zhang D, Potty A, Vyas P, Lane J (2014) The role of recombinant PTH in human fracture healing: a systematic review. J Orthop Trauma 28:57\u201362","journal-title":"J Orthop Trauma"},{"key":"665_CR24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1046\/j.1532-5415.2001.49177.x","volume":"49","author":"JA Yu-Yahiro","year":"2001","unstructured":"Yu-Yahiro JA, Michael RH, Dubin NH, Fox KM, Sachs M, Hawkes WG, Hebel JR, Zimmerman SI, Shapiro J, Magaziner J (2001) Serum and urine markers of bone metabolism during the year after hip fracture. J Am Geriatr Soc 49:877\u2013883","journal-title":"J Am Geriatr Soc"},{"key":"665_CR25","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1359\/jbmr.070505","volume":"22","author":"KK Ivaska","year":"2007","unstructured":"Ivaska KK, Gerdhem P, Akesson K, Garnero P, Obrant K (2007) Effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly women. J Bone Miner Res 22:1155\u20131164","journal-title":"J Bone Miner Res"},{"key":"665_CR26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s11999-007-0054-x","volume":"466","author":"T Ohishi","year":"2008","unstructured":"Ohishi T, Takahashi M, Yamanashi A, Suzuki D, Nagano A (2008) Sequential changes of bone metabolism in normal and delayed union of the spine. Clin Orthop Relat Res 466:402\u2013410","journal-title":"Clin Orthop Relat Res"},{"key":"665_CR27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s11999-011-2029-1","volume":"470","author":"A Unnanuntana","year":"2012","unstructured":"Unnanuntana A, Ton QV, Kleimeyer JP, Nguyen JT, Lane JM (2012) A fracture does not adversely affect bone mineral density responses after teriparatide treatment. Clin Orthop Relat Res 470:927\u2013936","journal-title":"Clin Orthop Relat Res"},{"key":"665_CR28","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2007-0711","volume":"93","author":"S Boonen","year":"2008","unstructured":"Boonen S, Marin F, Obermayer-Pietsch B, Simoes ME, Barker C, Glass EV, Hadji P, Lyritis G, Oertel H, Nickelsen T, McCloskey EV (2008) Effects of previous antiresorptive therapy on the bone mineral density response to 2\u00a0years of teriparatide treatment in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 93:852\u2013860","journal-title":"J Clin Endocrinol Metab"},{"key":"665_CR29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1530\/EJE-11-0740","volume":"166","author":"F Jakob","year":"2012","unstructured":"Jakob F, Oertel H, Langdahl B, Ljunggren O, Barrett A, Karras D, Walsh JB, Fahrleitner-Pammer A, Rajzbaum G, Barker C, Lems WF, Marin F (2012) Effects of teriparatide in postmenopausal women with osteoporosis pretreated with bisphosphonates: 36-month results from European forsteo observational study. Eur J Endocrinol 166:87\u201397","journal-title":"Eur J Endocrinol"},{"key":"665_CR30","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1359\/jbmr.080506","volume":"23","author":"B Obermayer-Pietsch","year":"2008","unstructured":"Obermayer-Pietsch B, Marin F, McCloskey EV, Hadji P, Farrerons J, Boonen S, Audran M, Barker C, Anastasilakis AD, Fraser WD, Nickelsen T (2008) Effects of 2\u00a0years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment. J Bone Miner Res 23:1591\u20131600","journal-title":"J Bone Miner Res"},{"key":"665_CR31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bone.2003.04.002","volume":"34","author":"RA Hannon","year":"2004","unstructured":"Hannon RA, Clowes JA, Eagleton AC, Hadari AA, Eastell R, Blumsohn A (2004) Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption. Bone 34:187\u2013194","journal-title":"Bone"},{"key":"665_CR32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00223-008-9127-4","volume":"82","author":"K Shidara","year":"2008","unstructured":"Shidara K, Inaba M, Okuno S, Yamada S, Kumeda Y, Imanishi Y, Yamakawa T, Ishimaru E, Nishizawa Y (2008) Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients. Calcif Tissue Int 82:278\u2013287","journal-title":"Calcif Tissue Int"},{"key":"665_CR33","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.bone.2009.07.091","volume":"45","author":"SJ Glover","year":"2009","unstructured":"Glover SJ, Eastell R, McCloskey EV, Rogers A, Garnero P, Lowery J, Belleli R, Wright TM, John MR (2009) Rapid and robust response of biochemical markers of bone formation to teriparatide therapy. Bone 45:1053\u20131058","journal-title":"Bone"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-015-0665-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-015-0665-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-015-0665-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T19:10:37Z","timestamp":1566760237000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-015-0665-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["665"],"URL":"https:\/\/doi.org\/10.1007\/s00774-015-0665-3","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,2]]}}}